Adjust text size: A | A | A

Lung Cancer Research Programs

2006

  • Lung cancer is the leading cause of cancer death worldwide and accounts for more deaths annually in the U.S. than breast, colon, and prostate cancer combined. Approximately 90% of lung cancer...

    | More…
  • The fact that women, even non-smokers, are at higher risk than men for developing a type of lung cancer called lung adenocarcinoma strongly suggests the involvement of gender-dependent factors in...

    | More…
  • The Laird-Offringa laboratory is focused on identifying changes in the genetic material (DNA) of lung cancer cells, to help us understand how lung cancer develops, and to use as markers for early...

    | More…
  • Lung cancer, rare in women in the early 1900s has reached epidemic proportions accounting for nearly 29% of all cancer deaths in females in the United States. Although lung tumors are classified...

    | More…
  • Lung cancer is the leading cause of cancer deaths in the United States. Bronchioalveolar carcinoma (BAC) is a type of lung cancer that is more likely to strike patients who are young, female and...

    | More…
  • Epidemiological studies indicate that lung cancer is the major cause of cancer-related deaths in the United States. Bronchioalveolar carcinoma (BAC), a subtype of lung cancer, often develops in...

    | More…
  • Peripheral lung adenocarcinoma, and bronchioalveolar carcinoma (BAC) in particular, continues to account for the majority of lung cancers in young (<55), non-smoking, women. BAC patients...

    | More…
  • Lung cancer is the leading cause of cancer deaths for men and women. The higher frequency of lung adenocarcinoma in women than in men, in both smokers and non-smokers, suggests that gender-...

    | More…

2005

  • Bronchioalveolar lung carcinoma (BAC) is a form of lung cancer for which etiology and pathogenesis are controversial. While squamous cell carcinomas and small cell carcinomas have shown an overall...

    | More…
  • Targeting proteins on the cell surface, called epidermal growth factor receptors (EGFR), is an effective therapy for a subset of lifelong non-smokers who develop lung cancer. Lifelong non-smokers...

    | More…

Spread the word

Share |

Sign up for Updates from Uniting

Uniting Against Lung Cancer: 27 Union Square West, Suite 304, New York, NY 10003 • Tel: 212.627.5500 • Fax: 212.627.7594. Privacy Policy
Uniting Against Lung Cancer is a tax exempt 501(c)(3) nonprofit corporation with the EIN 13 419 5464.

Site design & development by Raised Eyebrow Web Studio, Inc.